Walleye Trading’s Meridian Bioscience Inc VIVO Stock Holding History

Walleye Trading’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,500	Closed	-$282K	–	5693
2022 Q4	$282K	Buy	+8,500	New	+$274K	﹤0.01%	3300
2020 Q1	–	Sell	-20,792	Closed	-$203K	–	4757
2019 Q4	$203K	Buy	+20,792	New	+$195K	﹤0.01%	3153
2018 Q4	–	Sell	-1,800	Closed	-$27K	–	5519
2018 Q3	$27K	Buy	+1,800	New	+$27.9K	﹤0.01%	4766
2017 Q3	–	Sell	-3,400	Closed	-$54	–	4730
2017 Q2	$54	Buy	+3,400	New	+$49K	﹤0.01%	3858

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's VIVO Position: Q1 2023 in Review

Walleye Trading sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 8,500 shares — an estimated $282K sold.

Walleye Trading first reported a position in VIVO in Q2 2017 and held it in 4 quarters. The position peaked at $282K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Walleye Trading reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 8,500 Meridian Bioscience Inc shares in Q1 2023, an estimated $282K.
Walleye Trading first reported a position in Meridian Bioscience Inc in Q2 2017 and held it in 4 quarters.
Walleye Trading's Meridian Bioscience Inc position peaked at $282K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.